Instrumento Inactivo

Otros idiomas Nexstim Oyj Nasdaq Helsinki

Acciones

Health Canada Approves Nexstim NBS 6 System for Treatment of MDD	06/05
Nexstim plc Receives Approval from Health Canada for the Marketing and Commercial Distribution of Its NBS 6 System for the Treatment of Major Depressive Disorder	06/05
Nexstim, Inc. and Inomed Inc. Enter into Strategic Alliance Agreement for US Market	03/05
Neurosurgery Customer from Germany Orders Nexstim NBS System 5	26/04
Nexstim plc Receives Order for A New NBS System 5 from an Existing Customer Hospital in Germany	26/04
Nexstim Plc Business Update Q1 2024	26/04
Nexstim Plc: Managers’ Transactions, Hildén	25/04
Nexstim Plc: Managers’ Transactions, Forss	25/04
Nexstim Plc: Managers’ Transactions, Weckroth	25/04
Nexstim Plc: Managers’ Transactions, Niemistö	25/04
Nexstim Wins Order for Navigated Brain Stimulation System in US	22/04
Nexstim Receives NBS 6 System Order from Clinic in Florida, US	22/04
Nexstim Receives NBS 6 System Order from Clinic in Florida, US	22/04
Nexstim Plc Resolved on a New Stock Option Plan 2024H	12/04
Nexstim Plc: Resolutions of the Annual General Meeting of Shareholders	28/03
Nexstim Plc: Invitation to the Annual General Meeting	07/03
Nexstim : Financial Document	06/03
Nexstim Plc Publishes 2023 Annual Report	06/03
Nexstim Receives NBS System 5 Order from Neurosurgery Customer in Germany	28/02
Nexstim Receives NBS System 5 Order from Neurosurgery Customer in Germany	28/02

No hay resultados para esta búsqueda